Planning Capital Management Corp Immunity Bio, Inc. Transaction History
Planning Capital Management Corp
- $142 Billion
- Q2 2024
A detailed history of Planning Capital Management Corp transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Planning Capital Management Corp holds 14,757 shares of IBRX stock, worth $50,616. This represents 0.07% of its overall portfolio holdings.
Number of Shares
14,757
Previous 13,342
10.61%
Holding current value
$50,616
Previous $71.6 Million
30.17%
% of portfolio
0.07%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding IBRX
# of Institutions
219Shares Held
63.4MCall Options Held
1.44MPut Options Held
4.12M-
Vanguard Group Inc Valley Forge, PA13.8MShares$47.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$39.2 Million0.0% of portfolio
-
State Street Corp Boston, MA7.86MShares$27 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.92MShares$13.4 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY1.72MShares$5.89 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.37B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...